Institutional investors purchased a net $422.3 thousand shares of EDAP during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 9.95% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CLARIVEST ASSET MANAGEMENT LLC Sold 23.3 Thousand shares of Edap Tms SA